Rebecca Dann1, Tarik Hadi2, Emilie Montenont1, Ludovic Boytard2, Dornaszadat Alebrahim2, Jordyn Feinstein2, Nicole Allen1, Russell Simon2, Krista Barone2, Kunihiro Uryu3, Yu Guo1, Caron Rockman2, Bhama Ramkhelawon4, Jeffrey S Berger5. 1. Divisions of Cardiology and Hematology, Department Medicine, New York University School of Medicine, New York, New York. 2. Division of Vascular Surgery, Department of Surgery, New York University School of Medicine, New York, New York. 3. Electron Microscopy Resource Center, The Rockefeller University, New York, New York. 4. Division of Vascular Surgery, Department of Surgery, New York University School of Medicine, New York, New York; Department of Cell Biology, New York University School of Medicine, New York, New York. Electronic address: bhama.ramkhelawon@nyumc.org. 5. Divisions of Cardiology and Hematology, Department Medicine, New York University School of Medicine, New York, New York; Division of Vascular Surgery, Department of Surgery, New York University School of Medicine, New York, New York. Electronic address: Jeffrey.berger@nyumc.org.
Abstract
BACKGROUND: Peripheral artery disease (PAD), a diffuse manifestation of atherothrombosis, is a major cardiovascular threat. Although platelets are primary mediators of atherothrombosis, their role in the pathogenesis of PAD remains unclear. OBJECTIVES: The authors sought to investigate the role of platelets in a cohort of symptomatic PAD. METHODS: The authors profiled platelet activity, mRNA, and effector roles in patients with symptomatic PAD and in healthy controls. Patients with PAD and carotid artery stenosis were recruited into ongoing studies (NCT02106429 and NCT01897103) investigating platelet activity, platelet RNA, and cardiovascular disease. RESULTS: Platelet RNA sequence profiling mapped a robust up-regulation of myeloid-related protein (MRP)-14 mRNA, a potent calcium binding protein heterodimer, in PAD. Circulating activated platelets were enriched with MRP-14 protein, which augmented the expression of the adhesion mediator, P-selectin, thereby promoting monocyte-platelet aggregates. Electron microscopy confirmed the firm interaction of platelets with monocytes in vitro and colocalization of macrophages with MRP-14 confirmed their cross talk in atherosclerotic manifestations of PAD in vivo. Platelet-derived MRP-14 was channeled to monocytes, thereby fueling their expression of key PAD lesional hallmarks and increasing their directed locomotion, which were both suppressed in the presence of antibody-mediated blockade. Circulating MRP-14 was heightened in the setting of PAD, significantly correlated with PAD severity, and was associated with incident limb events. CONCLUSIONS: The authors identified a heightened platelet activity profile and unraveled a novel immunomodulatory effector role of platelet-derived MRP-14 in reprograming monocyte activation in symptomatic PAD. (Platelet Activity in Vascular Surgery and Cardiovascular Events [PACE]; NCT02106429; and Platelet Activity in Vascular Surgery for Thrombosis and Bleeding [PIVOTAL]; NCT01897103).
BACKGROUND:Peripheral artery disease (PAD), a diffuse manifestation of atherothrombosis, is a major cardiovascular threat. Although platelets are primary mediators of atherothrombosis, their role in the pathogenesis of PAD remains unclear. OBJECTIVES: The authors sought to investigate the role of platelets in a cohort of symptomatic PAD. METHODS: The authors profiled platelet activity, mRNA, and effector roles in patients with symptomatic PAD and in healthy controls. Patients with PAD and carotid artery stenosis were recruited into ongoing studies (NCT02106429 and NCT01897103) investigating platelet activity, platelet RNA, and cardiovascular disease. RESULTS: Platelet RNA sequence profiling mapped a robust up-regulation of myeloid-related protein (MRP)-14 mRNA, a potent calcium binding protein heterodimer, in PAD. Circulating activated platelets were enriched with MRP-14 protein, which augmented the expression of the adhesion mediator, P-selectin, thereby promoting monocyte-platelet aggregates. Electron microscopy confirmed the firm interaction of platelets with monocytes in vitro and colocalization of macrophages with MRP-14 confirmed their cross talk in atherosclerotic manifestations of PAD in vivo. Platelet-derived MRP-14 was channeled to monocytes, thereby fueling their expression of key PAD lesional hallmarks and increasing their directed locomotion, which were both suppressed in the presence of antibody-mediated blockade. Circulating MRP-14 was heightened in the setting of PAD, significantly correlated with PAD severity, and was associated with incident limb events. CONCLUSIONS: The authors identified a heightened platelet activity profile and unraveled a novel immunomodulatory effector role of platelet-derived MRP-14 in reprograming monocyte activation in symptomatic PAD. (Platelet Activity in Vascular Surgery and Cardiovascular Events [PACE]; NCT02106429; and Platelet Activity in Vascular Surgery for Thrombosis and Bleeding [PIVOTAL]; NCT01897103).
Authors: Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley Journal: Nat Med Date: 2002-12-16 Impact factor: 53.440
Authors: A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt Journal: JAMA Date: 2001-09-19 Impact factor: 56.272
Authors: Prabhakara R Nagareddy; Andrew J Murphy; Roslynn A Stirzaker; Yunying Hu; Shiquing Yu; Rachel G Miller; Bhama Ramkhelawon; Emilie Distel; Marit Westerterp; Li-Shin Huang; Ann Marie Schmidt; Trevor J Orchard; Edward A Fisher; Alan R Tall; Ira J Goldberg Journal: Cell Metab Date: 2013-05-07 Impact factor: 27.287
Authors: Michael S Garshick; Michael Tawil; Tessa J Barrett; Charissa M Salud-Gnilo; Michael Eppler; Angela Lee; Jose U Scher; Andrea L Neimann; Sanja Jelic; Nehal N Mehta; Edward A Fisher; James G Krueger; Jeffrey S Berger Journal: Arterioscler Thromb Vasc Biol Date: 2020-03-05 Impact factor: 8.311
Authors: Tessa J Barrett; Emilie Distel; Andrew J Murphy; Jiyuan Hu; Michael S Garshick; Yoscar Ogando; Jianhua Liu; Tomas Vaisar; Jay W Heinecke; Jeffrey S Berger; Ira J Goldberg; Edward A Fisher Journal: Circulation Date: 2019-09-30 Impact factor: 29.690
Authors: Tessa J Barrett; Martin Schlegel; Felix Zhou; Mike Gorenchtein; Jennifer Bolstorff; Kathryn J Moore; Edward A Fisher; Jeffrey S Berger Journal: Sci Transl Med Date: 2019-11-06 Impact factor: 17.956
Authors: Verena Rolfes; Lucas Secchim Ribeiro; Ibrahim Hawwari; Lisa Böttcher; Nathalia Rosero; Salie Maasewerd; Marina Lima Silva Santos; Tomasz Próchnicki; Camila Meirelles de Souza Silva; Carlos Wagner de Souza Wanderley; Maximilian Rothe; Susanne V Schmidt; H James Stunden; Damien Bertheloot; Magali Noval Rivas; Cor Jesus Fontes; Luzia Helena Carvalho; Fernando Queiroz Cunha; Eicke Latz; Moshe Arditi; Bernardo Simoes Franklin Journal: Cell Rep Date: 2020-05-12 Impact factor: 9.423
Authors: Eugenio D Hottz; Isaclaudia G Azevedo-Quintanilha; Lohanna Palhinha; Lívia Teixeira; Ester A Barreto; Camila R R Pão; Cassia Righy; Sérgio Franco; Thiago M L Souza; Pedro Kurtz; Fernando A Bozza; Patrícia T Bozza Journal: Blood Date: 2020-09-10 Impact factor: 22.113
Authors: Sean P Heffron; Ada Weinstock; Bianca Scolaro; Shiyu Chen; Brian E Sansbury; Greg Marecki; Christina C Rolling; Hanane El Bannoudi; Tessa Barrett; James W Canary; Matthew Spite; Jeffrey S Berger; Edward A Fisher Journal: J Thromb Haemost Date: 2020-12-03 Impact factor: 5.824